| 2021 | ACCELERON PHARMA : Jefferies Starts Acceleron Pharma at Hold With $180 Price Target | MT |
| 2021 | ACCELERON PHARMA : Raymond James Downgrades Acceleron Pharma to Market Perform From Strong.. | MT |
| 2021 | ACCELERON PHARMA : Oppenheimer Suspends Rating for Acceleron Pharma, $160 Price Target on .. | MT |
| 2021 | ACCELERON PHARMA : Morgan Stanley Downgrades Acceleron Pharma to Equalweight from Overweig.. | MT |
| 2021 | ACCELERON PHARMA : Barclays Downgrades Acceleron Pharma to Equal-Weight Rating From Overwe.. | MT |
| 2021 | ACCELERON PHARMA : Cowen Downgrades Acceleron Pharma to Market Perform from Outperform, Bo.. | MT |
| 2021 | ANALYST RECOMMENDATIONS : Acceleron Pharma, General Mills, Southwest Airlines, Home Depot,.. | |
| 2021 | ACCELERON PHARMA : HC Wainwright Downgrades Acceleron Pharma to Neutral Rating From Buy, A.. | MT |
| 2021 | ACCELERON PHARMA : RBC Capital Again Raises Price Target for Acceleron Pharma to $180 From.. | MT |
| 2021 | ACCELERON PHARMA : SVB Leerink Adjusts Acceleron Pharma PT to $180 from $148, Keeps Market.. | MT |
| 2021 | ACCELERON PHARMA : Piper Sandler Downgrades Acceleron Pharma to Neutral from Overweight, A.. | MT |
| 2021 | ACCELERON PHARMA : RBC Boosts Price Target on Acceleron Pharma to $179 From $113, Citing D.. | MT |
| 2021 | ACCELERON PHARMA : RBC Raises Price Target on Acceleron Pharma to $113 From $111, Reiterat.. | MT |
| 2021 | ANALYST RECOMMENDATIONS : Accenture, Comcast, DoorDash, Intel, Roku... | |
| 2021 | ACCELERON PHARMA : Oppenheimer Adjusts Acceleron Pharma PT to $160 From $141, Maintains Ou.. | MT |
| 2021 | ACCELERON PHARMA : Oppenheimer Adjusts Acceleron Pharma PT to $141 From $140, Maintains Ou.. | MT |
| 2021 | ACCELERON PHARMA : SVB Leerink Downgrades Acceleron Pharma to Market Perform From Outperfo.. | MT |
| 2021 | ACCELERON PHARMA : Goldman Sachs Analyst Assumes Coverage of Acceleron Pharma With Neutral.. | MT |
| 2021 | ACCELERON PHARMA : Wolfe Research Starts Acceleron Pharma at Outperform With $200 Price Ta.. | MT |
| 2021 | ACCELERON PHARMA : Citigroup Adjusts Acceleron Pharma's Price Target to $171 from $137, Ke.. | MT |
| 2021 | ACCELERON PHARMA : SVB Leerink Adjusts Price Target on Acceleron Pharma to $148 From $138,.. | MT |
| 2021 | ACCELERON PHARMA : Morgan Stanley Adjusts Acceleron Pharma PT to $145 From $135, Maintains.. | MT |
| 2021 | ACCELERON PHARMA : JP Morgan Adjusts Acceleron Pharma's Price Target to $153 from $133, Ke.. | MT |
| 2020 | ACCELERON PHARMA : Barclays Adjusts Acceleron Pharma PT to $150 From $133, Maintains Overw.. | MT |
| 2020 | ACCELERON PHARMA : Morgan Stanley Adjusts Acceleron Pharma PT to $135 From $130, Maintains.. | MT |
| 2020 | ACCELERON PHARMA : Oppenheimer Adjusts Acceleron Pharma's Price Target to $131 from $120 o.. | MT |
| 2020 | ACCELERON PHARMA : Oppenheimer Adjusts Acceleron Pharma's Price Target to $120 From $126, .. | MT |
| 2020 | ACCELERON PHARMA : HC Wainwright Adjusts Acceleron Pharma's Price Target to $148 From $137.. | MT |
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
